E/M Coding Alert - 2007 Issue 22
PHYSICIAN NOTES: Switch To Q Codes For Albuterol, Levalbuterol
Subscribe or sign in to view the full article.
Article Overview
This article is a Medicare-focused physician coding and reimbursement update. It explains a payment change affecting nebulized inhalation drug claims and also touches on related topics such as beneficiary disenrollment issues in Medicare Advantage, CMS demonstration results, physician attitudes toward PQRI, and an OIG report on wound therapy coverage. It is relevant to practices that bill Medicare, especially pulmonary, home health, and other physician offices that follow Medicare policy updates.
Why This Topic Matters
The piece flags a billing change that affects how certain inhalation drug claims are handled under Medicare Part B and notes related administrative issues that can affect payment, coverage, and compliance across several care settings.
Article Sections
-
Medicare Part B inhalation drug billing update
Covers a Medicare payment update for nebulized inhalation drugs and related billing workflow impacts for practices that furnish these services.
-
Additional Medicare and physician policy news
Summarizes other reported developments involving Medicare Advantage disenrollment, a CMS physician group demonstration, the PQRI, and wound therapy coverage oversight.
What You Will Learn
- What Medicare billing area is affected by the inhalation drug payment update
- What broader Medicare policy topics are discussed alongside the coding news
- Which organizations and programs are referenced in the article
- Why the article is relevant to practices that bill Medicare
Who Should Read This
- Physician office billers and coders
- Pulmonary practices
- Home health agencies
- Medicare billing staff
- Practice administrators
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com